首页> 外文OA文献 >Identification of potential herbal inhibitor of acetylcholinesterase associated alzheimer’s disorders using molecular docking and molecular dynamics simulation
【2h】

Identification of potential herbal inhibitor of acetylcholinesterase associated alzheimer’s disorders using molecular docking and molecular dynamics simulation

机译:使用分子对接和分子动力学模拟鉴定潜在的草药抑制剂乙酰胆碱酯酶相关的阿尔茨海默氏病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cholinesterase inhibitors (ChE-Is) are the standard for the therapy of AD associated disorders and are the only class of approved drugs by the Food and Drug Administration (FDA). Additionally, acetylcholinesterase (AChE) is the target for many Alzheimer’s dementia drugs which block the function of AChE but have some side effects. Therefore, in this paper, an attempt was made to elucidate cholinesterase inhibition potential of secondary metabolite from Cannabis plant which has negligible or no side effect. Molecular docking of 500 herbal compounds, against AChE, was performed using Autodock 4.2 as per the standard protocols. Molecular dynamics simulations have also been carried out to check stability of binding complex in water for 1000 ps. Our molecular docking and simulation have predicted high binding affinity of secondary metabolite () to AChE. Further, molecular dynamics simulations for 1000 ps suggest that ligand interaction with the residues Asp72, Tyr70-121-334, and Phe288 of AChE, all of which fall under active site/subsite or binding pocket, might be critical for the inhibitory activity of AChE. This approach might be helpful to understand the selectivity of the given drug molecule in the treatment of Alzheimer's disease. The study provides evidence for consideration of as a valuable small ligand molecule in treatment and prevention of AD associated disorders and further in vitro and in vivo investigations may prove its therapeutic potential.
机译:胆碱酯酶抑制剂(ChE-Is)是治疗AD相关疾病的标准,并且是美国食品药品监督管理局(FDA)唯一批准的药物类别。此外,乙酰胆碱酯酶(AChE)是许多阿尔茨海默氏症痴呆药物的靶标,这些药物可阻断AChE的功能,但有一些副作用。因此,在本文中,试图阐明大麻植物次级代谢产物对胆碱酯酶的抑制潜能,该潜能具有可忽略的副作用或无副作用。根据标准规程,使用Autodock 4.2对500种草药化合物进行抗AChE分子对接。还进行了分子动力学模拟,以检查结合复合物在水中的稳定度为1000 ps。我们的分子对接和模拟预测了次级代谢产物()对AChE的高结合亲和力。此外,对1000 ps的分子动力学模拟表明,配体与AChE的残基Asp72,Tyr70-121-334和Phe288的相互作用都对AChE的抑制活性至关重要,这些残基都位于活性位点/亚位点或结合口袋之下。 。该方法可能有助于理解给定药物分子在治疗阿尔茨海默氏病中的选择性。该研究提供了证据,认为其可作为治疗和预防AD相关疾病的有价值的小配体分子,进一步的体外和体内研究可能证明其具有治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号